Claims
- 1. A method of reducing a boron concentration in a high-salinity boron-containing liquid comprising the following steps:
(a) adjusting a pH of the high salinity liquid to about 8 to about 9.5; (b) passing the high-salinity liquid through a reverse osmosis device; and (c) recovering a permeate from the reverse osmosis device wherein the permeate has a boron concentration of less than about 2 ppm.
- 2. The method of claim 1, wherein the high salinity liquid is seawater.
- 3. The method of claim 2, wherein the seawater comprises about 4 to about 7 ppm of boron.
- 4. The method of claim 1, wherein the pH of the high salinity liquid is adjusted to about 8 to about 9.3.
- 5. The method of claim 1, wherein step (a) comprises adding a base to the high salinity liquid.
- 6. The method of claim 5, wherein the base is selected from the group consisting of calcium hydroxide, sodium hydroxide and lime.
- 7. The method of claim 1, wherein the reverse osmosis device comprises an array comprising at least one reverse osmosis membrane.
- 8. The method of claim 7, wherein the at least one reverse osmosis membrane is a polyamide-type membrane.
- 9. The method of claim 7, wherein the at least one reverse osmosis membrane is selected from the group consisting of a spiral wound membrane and a hollow fiber membrane.
- 10. The method of claim 1, further comprising adding a scale inhibitor to the high salinity liquid before step (b).
- 11. The method of claim 1, wherein the permeate has a boron concentration of less than about 1 ppm.
- 12. The method of claim 11, wherein the permeate has a boron concentration of less than about 0.5 ppm.
- 13. The method of claim 1, further comprising (d) passing the permeate of step (c) through a further reverse osmosis device to further reduce the boron concentration.
- 14. The method of claim 1, further comprising at least before step (b) treating the high salinity liquid with a membrane filtration system to remove at least one suspended solid from the liquid.
- 15. The method according to claim 14, wherein the treating step is carried out before step (a).
- 16. The method of claim 14, wherein the membrane filtration system is selected from the group consisting of an ultrafiltration system and a microfiltration system.
- 17. The method of claim 16, wherein the membrane filtration system comprises a membrane module selected from the group consisting of an ultrafiltration membrane module and a microfiltration membrane module.
- 18. The method of claim 17, wherein the ultrafiltration or microfiltration membrane module comprises a membrane selected from the group consisting of spiral wound and capillary type membranes.
- 19. The method of claim 14, further comprising adding at least one coagulant chemical to the high salinity liquid prior to the treating step.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Application No. 60/388,256, filed Jun. 13, 2002, and U.S. Provisional Application No. 60/443,363, filed Jan. 29, 2003, and is a continuation-in-part of co-pending application Ser. No. 10/188,476, filed Jul. 3, 2002, the disclosures of which are incorporated herein by reference.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60388256 |
Jun 2002 |
US |
|
60443363 |
Jan 2003 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
10188476 |
Jul 2002 |
US |
Child |
10460697 |
Jun 2003 |
US |